|
Market Closed -
Nasdaq
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 20.38 USD | -0.49% |
|
+6.26% | +61.75% |
| 09-23 | Amneal Pharmaceuticals' Biosimilars, Specialty Growth Reshape Earnings Profile, Oppenheimer Says | MT |
| 09-23 | Oppenheimer Initiates Amneal Pharmaceuticals at Outperform With $27 Price Target | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMRX | Delayed | |
CBOE
| AMRX | Real-time | |
|
Börse Stuttgart
| 2DT | Delayed | |
|
Deutsche Boerse AG
| 2DT | Delayed | |
|
Tradegate
| 2DT | Real-time | |
|
Boerse Muenchen
| 2DT | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 20.5 | 20.5 | 24.09 |
| Spread/Res. | -0.59% | -0.59% | -15.40% |
| Spread/Supp. | +10.64% | +26.51% | +37.52% |
| Support | 18.42 | 16.11 | 14.82 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AMRX Stock
- Charts Amneal Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
